Duke Recruiting Patients for Autism Study

The Marcus Center for Cellular Cures and Duke Center for Autism and Brain Development are currently recruiting patients—4 to 11 years of age, who are diagnosed with Autism Spectrum Disorder to participate in a Phase II randomized (flip of a coin), blinded, placebo-controlled clinical trial, testing whether an IV infusion of hCT-MSCs helps decrease symptoms of Autism in young children.

All participants will receive 2 IV infusions given six months apart. One infusion will be hCT-MSCs, and one will be an inactive placebo product. Participants and families will not know the order in which the products are given.

Participant reimbursement will be provided after the baseline visit and the one-year remote visit.

If you are interested in participating, go to https://redcap.duke.edu/redcap/surveys/?s=8NEFPMX8A7

For more information, go to this link on the clinicaltrials.gov website, https://clinicaltrials.gov/ct2/show/NCT04089579